Evidence map›Paper›PMID 37125284›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2023

How an innovative catheter with temperature control and very high-power, short-duration ablation changed our approach to the treatment of persistent atrial fibrillation.

Giovanni Volpato, Paolo Compagnucci, Laura Cipolletta, Quintino Parisi, Yari Valeri, Giulia Santarelli, Michela Colonnelli, Michela Casella, Antonio Dello Russo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giovanni VolpatoCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Via Conca 71, 60126 Ancona, Italy.
Paolo CompagnucciCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Via Conca 71, 60126 Ancona, Italy.
Laura CipollettaCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Via Conca 71, 60126 Ancona, Italy.
Quintino ParisiCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Via Conca 71, 60126 Ancona, Italy.
Yari ValeriCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Via Conca 71, 60126 Ancona, Italy.
Giulia SantarelliCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Via Conca 71, 60126 Ancona, Italy.
Michela ColonnelliCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Via Conca 71, 60126 Ancona, Italy.
Michela CasellaCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Via Conca 71, 60126 Ancona, Italy.
Antonio Dello RussoCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Via Conca 71, 60126 Ancona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ablation targets of persistent atrial fibrillation remain poorly understood nowadays: due to structural alterations of the left atrium, isolation of the pulmonary veins alone has proved ineffective. New ablation targets such as the posterior wall, coronary sinus, and left atrial appendage were then sought. A new catheter (QDOT Micro™) has recently been released, which has the potential to increase the safety and efficacy of the procedure: it is connected to a new radiofrequency generator that allows for temperature-controlled ablation by reducing power and increasing irrigation with the increase in tissue temperature and allows to deliver power up to 90 W for few seconds (very high-power short-duration).

Indexed as

Left atrial posterior wall ablationMicrobipolar mappingPersistent atrial fibrillationVery high-power short-duration ablation

Identifiers

PMID37125284
PMCPMC10132567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.